Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...

These updates approved the use of this treatment either with or without statins. As an adenosine triphosphate-citrate lyase (ACL) inhibitor, this medication works by blocking a protein in your ...

Further reductions in HCC and hepatic decompensation risks were seen in association with exposure to lipophilic statins and duration of statin use (≥600 cumulative defined daily dose). Among 7,038 ...